Cure My Disease

Don't miss your cure!

 Log in / Sign up

Redesigned catheter aims to make angiograms safer and more precise

NCT ID NCT06986954

Knowledge-focused Sponsor: Cook Research Incorporated Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study follows about 800 people undergoing angiographic procedures with redesigned Beacon Tip catheters. The goal is to see if the catheters can be safely navigated to the intended location and used for tasks like releasing contrast dye or taking anatomical measurements. Researchers will track major complications within 30 days of the procedure. The data will be used to support regulatory approval in Europe and other regions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Beacon Tip Catheters (device)
What this could lead to
If successful, this study could support regulatory approval for improved catheters that help doctors perform angiograms and anatomical measurements more safely.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove the device is better than others. Complications like bleeding or stroke are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

816 people

The number who actually took part.

Started

Apr 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The patient population for this study will be patients receiving care at the 8 office-based labs (OBLs) consisting of 14 sites, all part of the Data Collection Center, Vascular Breakthroughs. These patients will not be constrained to a specific demographic, but rather will be any person who undergoes a procedure using a Beacon Tip Catheter(s).

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A patient is deemed suitable for inclusion in this study if the patient undergoes a procedure using an applicable Beacon Tip Catheter. Exclusion Criteria: * Patient or his/her legally authorized representative objects to collection and processing of his/her data, or not willing to accept the use of an Informed Consent waiver or the data protection notice (if utilized).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bleed intracranial are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm, False Constriction, Pathologic intracerebral hemorrhage Intracranial Hemorrhages stroke disorder transient ischemic attack vascular malformation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bleed intracranial Pseudoaneurysm Stenosis Stroke TIA Vascular malformation

Contacts and locations

Locations

  • Vascular Breakthroughs

    Darien, Connecticut, 06820, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.